315.42美元2.2(0.7%)
2024/10/11更新
績效 / 1月0.78%
3月1.85%
1年17.69%
晨星評等 - 1.現金0.36%
- 2.股票44.38%
- 3.債券0.00%
- 4.其他55.26%
- 1.美國55.25%
- 2.歐洲不包含歐元區24.45%
- 3.歐元區11.17%
- 4.英國7.67%
- 5.日本1.09%
- 1.健康護理73.58%
- 2.周期性消費7.67%
- 3.基本物料5.79%
- 4.科技5.67%
- 5.防守性消費5.60%
- 6.工業1.33%
- 1.Eli Lilly and Co6.63%
- 2.Novo Nordisk AS Class B5.95%
- 3.Thermo Fisher Scientific Inc5.58%
- 4.Boston Scientific Corp5.31%
- 5.Intuitive Surgical Inc4.87%
- 6.UnitedHealth Group Inc4.45%
- 7.AstraZeneca PLC4.11%
- 8.Lonza Group Ltd4.11%
- 9.Steris PLC3.72%
- 10.Danaher Corp3.54%
- 1.現金0.36%
- 2.股票44.38%
- 3.債券0.00%
- 4.其他55.26%
- 1.健康護理73.58%
- 2.周期性消費7.67%
- 3.基本物料5.79%
- 4.科技5.67%
- 5.防守性消費5.60%
- 6.工業1.33%
- 1.美國55.25%
- 2.歐洲不包含歐元區24.45%
- 3.歐元區11.17%
- 4.英國7.67%
- 5.日本1.09%
- 1.Eli Lilly and Co6.63%
- 2.Novo Nordisk AS Class B5.95%
- 3.Thermo Fisher Scientific Inc5.58%
- 4.Boston Scientific Corp5.31%
- 5.Intuitive Surgical Inc4.87%
- 6.UnitedHealth Group Inc4.45%
- 7.AstraZeneca PLC4.11%
- 8.Lonza Group Ltd4.11%
- 9.Steris PLC3.72%
- 10.Danaher Corp3.54%